rs779364501

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_032777.10(ADGRA2):​c.1009G>A​(p.Ala337Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,461,528 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

ADGRA2
NM_032777.10 missense

Scores

18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.488

Publications

1 publications found
Variant links:
Genes affected
ADGRA2 (HGNC:17849): (adhesion G protein-coupled receptor A2) Predicted to enable G protein-coupled receptor activity. Involved in positive regulation of canonical Wnt signaling pathway. Part of Wnt signalosome. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.048289955).
BS2
High AC in GnomAdExome4 at 20 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADGRA2NM_032777.10 linkc.1009G>A p.Ala337Thr missense_variant Exon 8 of 19 ENST00000412232.3 NP_116166.9 Q96PE1-1Q6YN44
ADGRA2XM_011544481.3 linkc.1009G>A p.Ala337Thr missense_variant Exon 8 of 19 XP_011542783.1
ADGRA2XM_011544482.3 linkc.937G>A p.Ala313Thr missense_variant Exon 7 of 18 XP_011542784.1
ADGRA2XM_011544483.3 linkc.1009G>A p.Ala337Thr missense_variant Exon 8 of 18 XP_011542785.1 D3DSW5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADGRA2ENST00000412232.3 linkc.1009G>A p.Ala337Thr missense_variant Exon 8 of 19 1 NM_032777.10 ENSP00000406367.2 Q96PE1-1
ADGRA2ENST00000315215.11 linkc.1009G>A p.Ala337Thr missense_variant Exon 8 of 16 1 ENSP00000323508.7 Q96PE1-2

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000798
AC:
2
AN:
250740
AF XY:
0.0000147
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000882
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000137
AC:
20
AN:
1461528
Hom.:
0
Cov.:
32
AF XY:
0.0000138
AC XY:
10
AN XY:
727102
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33478
American (AMR)
AF:
0.00
AC:
0
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53086
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000153
AC:
17
AN:
1111986
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 06, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1009G>A (p.A337T) alteration is located in exon 8 (coding exon 8) of the ADGRA2 gene. This alteration results from a G to A substitution at nucleotide position 1009, causing the alanine (A) at amino acid position 337 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
14
DANN
Benign
0.92
DEOGEN2
Benign
0.090
.;T
Eigen
Benign
-0.63
Eigen_PC
Benign
-0.41
FATHMM_MKL
Benign
0.69
D
LIST_S2
Benign
0.69
T;T
M_CAP
Benign
0.0065
T
MetaRNN
Benign
0.048
T;T
MetaSVM
Benign
-1.0
T
PhyloP100
0.49
PrimateAI
Benign
0.29
T
PROVEAN
Benign
0.040
N;N
REVEL
Benign
0.052
Sift
Benign
0.86
T;T
Sift4G
Benign
0.65
T;T
Polyphen
0.024
B;B
Vest4
0.22
MutPred
0.33
Loss of sheet (P = 0.0315);Loss of sheet (P = 0.0315);
MVP
0.12
MPC
0.26
ClinPred
0.067
T
GERP RS
3.1
Varity_R
0.019
gMVP
0.30
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs779364501; hg19: chr8-37689017; COSMIC: COSV59444588; COSMIC: COSV59444588; API